Literature DB >> 1656205

The effect of ischaemia and reperfusion on sarcolemmal inositol phospholipid and cytosolic inositol phosphate metabolism in the isolated perfused rat heart.

R Mouton1, B Huisamen, A Lochner.   

Abstract

In this study the mass of polyphosphoinositides as well as the turnover of [3H]inositol phospholipids and [3H]inositol phosphates during ischaemia and short periods of reperfusion were studied in the isolated perfused rat heart. Since the phosphoinositides located within the sarcolemma are precursors for release of inositoltrisphosphate (InsP3) and diacylglycerol, sarcolemmal membranes (rather than whole tissue) isolated at the end of the experimental procedure, were used. Hearts were prelabelled with [3H]inositol and subsequently perfused with 10 mM LiCl to block the phosphatidylinositol (PI) pathway. The results showed that 20 min of global ischaemia depressed the amount of [3H]inositol present in both sarcolemmal phosphatidylinositol-4-phosphate (PI-4-P) and phsophatidylinositol-4,5-bisphosphate (PI-4,5-P2), as well as in the cytosolic [3H]inositol phosphates, [3H]InsP2 and [3H]InsP3. The mass of the sarcolemmal inositol phospholipids remained unchanged during ischaemia. Reperfusion caused an immediate (within 30 sec) increase in the amount of [3H]inositol in sarcolemmal PI, PI-4-P and PI-4,5-P2. PI-4-P levels showed a transient increase after 30 seconds postischaemic reperfusion, while the mass of the other sarcolemmal inositol phospholipids, PI and PI-4,5-P2, remained unchanged. [3H]InsP, [3H]InsP2 and [3H]InsP3 also increased significantly in comparison to ischaemic hearts after only 30 sec postischaemic reperfusion. In summary, the results obtained indicate inhibition of the PI pathway during ischaemia with an immediate significant stimulation upon reperfusion. In view of the capacity of InsP3 to mobilize Ca2+, the possibility exists that stimulation of this pathway during reperfusion may play a role in the intracellular Ca2+ overload, characteristic of postischaemic reperfusion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656205     DOI: 10.1007/bf00227752

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

1.  Phosphoinositide kinases in chick brain and sciatic nerve, a developmental study.

Authors:  N A Shaikh; F B Palmer
Journal:  J Neurochem       Date:  1977-02       Impact factor: 5.372

Review 2.  Receptors and phosphoinositide-generated second messengers.

Authors:  L E Hokin
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  Inositol trisphosphate enhances calcium release in skinned cardiac and skeletal muscle.

Authors:  T M Nosek; M F Williams; S T Zeigler; R E Godt
Journal:  Am J Physiol       Date:  1986-05

4.  Improved conditions for the preservation and extraction of polyphosphoinositides.

Authors:  G Hauser; J Eichberg
Journal:  Biochim Biophys Acta       Date:  1973-11-29

5.  Effects of phospholipid fatty acid composition and membrane fluidity on the activity of bovine brain phospholipid exchange protein.

Authors:  G M Helmkamp
Journal:  Biochemistry       Date:  1980-05-13       Impact factor: 3.162

6.  Enhanced phosphodiesteratic breakdown and turnover of phosphoinositides during reperfusion of ischemic rat heart.

Authors:  H Otani; M R Prasad; R M Engelman; H Otani; G A Cordis; D K Das
Journal:  Circ Res       Date:  1988-11       Impact factor: 17.367

7.  Bovine brain phosphatidylinositol transfer protein. Effects of pH, ionic strength and lipid composition on transfer activity.

Authors:  T Yoshimura; G M Helmkamp
Journal:  Biochim Biophys Acta       Date:  1984-05-11

8.  Alpha 1-adrenergic and muscarinic cholinergic stimulation of phosphoinositide hydrolysis in adult rat cardiomyocytes.

Authors:  J H Brown; I L Buxton; L L Brunton
Journal:  Circ Res       Date:  1985-10       Impact factor: 17.367

Review 9.  Inositol trisphosphate, a novel second messenger in cellular signal transduction.

Authors:  M J Berridge; R F Irvine
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

10.  An unusual phosphatidylinositol turnover pathway in noradrenaline-perfused rat hearts.

Authors:  E A Woodcock; A I Smith; C A Wallace; L B White
Journal:  Clin Exp Pharmacol Physiol       Date:  1988-04       Impact factor: 2.557

View more
  6 in total

1.  Signal transduction in myocardial ischaemia and reperfusion.

Authors:  A Lochner; E Tromp; R Mouton
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

2.  Effects of ischaemia, reperfusion and alpha 1-adrenergic receptor stimulation on the inositoltrisphosphate receptor population in rat heart atria and ventricles.

Authors:  B Huisamen; R Mouton; L H Opie; A Lochner
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

3.  No contribution of IP3-R(2) to disease phenotype in models of dilated cardiomyopathy or pressure overload hypertrophy.

Authors:  Nicola Cooley; Kunfu Ouyang; Julie R McMullen; Helen Kiriazis; Farah Sheikh; Wei Wu; Yongxin Mu; Xiao-Jun Du; Ju Chen; Elizabeth A Woodcock
Journal:  Circ Heart Fail       Date:  2012-12-20       Impact factor: 8.790

4.  Phosphatidylinositol-bisphosphate regulates intercellular coupling in cardiac myocytes.

Authors:  Johannes P Hofgaard; Kathrin Banach; Sarah Mollerup; Helene Korvenius Jørgensen; Søren Peter Olesen; Niels-Henrik Holstein-Rathlou; Morten Schak Nielsen
Journal:  Pflugers Arch       Date:  2008-06-07       Impact factor: 3.657

5.  Potential mechanisms for the enhancement of HERG K+ channel function by phospholipid metabolites.

Authors:  Jingxiong Wang; Yiqiang Zhang; Huizhen Wang; Hong Han; Stanley Nattel; Baofeng Yang; Zhiguo Wang
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

6.  The effect of ischaemia-reperfusion on [3H]inositol phosphates and ins(1,4,5)P3 levels in cardiac atria and ventricles--a comparative study.

Authors:  R Mouton; S Genade; B Huisamen; M Malan; A Lochner
Journal:  Mol Cell Biochem       Date:  1992-10-07       Impact factor: 3.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.